|
|||||
|
|
Criteria for the choice and definition of healthy volunteers and or patients for phase I and phase II studies in drug development |
|
| Authors: | P. R. Bechtel G. Alvan |
| Affiliation: | (1) Service de Pharmacologie Clinique-CHU Jean Minjoz, Besançon, France;(2) Department of Clinical Pharmacology, Huddinge Hospital, Huddinge, Sweden |
| Abstract: | |
| Keywords: | clinical pharmacology pharmacogenetics drug development genetic polymorphism phase I-/phase II studies choice of participants international cooperation |
| 本文献已被 SpringerLink 等数据库收录！ | |